- A Novel Angiotensin Type I Receptor Antagonist, Fimasartan, Prevents Doxorubicin-induced Cardiotoxicity in Rats
-
Chang SA, Lim BK, Lee YJ, Hong MK, Choi JO, Jeon ES
- KMID: 2155468
- J Korean Med Sci.
- 2015 May;30(5):559-568.
- doi: 10.3346/jkms.2015.30.5.559
Angiotensin receptor blockers (ARBs) have organ-protective effects in heart failure and may be also effective in doxorubicin-induced cardiomyopathy (DOX-CMP); however, the efficacy of ARBs on the prevention of DOX-CMP have... -
- CITED
-
- Close
- SHARE
-
- Close
- An Angiotensin Receptor Blocker Prevents Arrhythmogenic Left Atrial Remodeling in a Rat Post Myocardial Infarction Induced Heart Failure Model
-
Kim HS, No CW, Goo SH, Cha TJ
- KMID: 1777557
- J Korean Med Sci.
- 2013 May;28(5):700-708.
- doi: 10.3346/jkms.2013.28.5.700
This study investigated the role of angiotensin II receptor blocker in atrial remodeling in rats with atrial fibrillation (AF) induced by a myocardial infarction (MI). MIs were induced by a... -
- CITED
-
- Close
- SHARE
-
- Close
- Cardioprotective Effect of Fimasartan, a New Angiotensin Receptor Blocker, in a Porcine Model of Acute Myocardial Infarction
-
Sim DS, Jeong MH, Song HC, Kim J, Chong A, Bom HS, Jeong IS, Oh SG, Kim JM, Park DS, Kim JH, Lim KS, Kim MS, Ryu SH, Kim HK, Kim SS, Jang SY, Cho JY, Jeong HC, Lee KH, Park KH, Yoon NS, Yoon HJ, Kim KH, Hong YJ, Park HW, Kim JH, Ahn Y, Cho JG, Park JC, Kang JC
- KMID: 2155445
- J Korean Med Sci.
- 2015 Jan;30(1):34-43.
- doi: 10.3346/jkms.2015.30.1.34
Cardioprotective effect of fimasartan, a new angiotensin receptor blocker (ARB), was evaluated in a porcine model of acute myocardial infarction (MI). Fifty swine were randomized to group 1 (sham, n=10),... -
- CITED
-
- Close
- SHARE
-
- Close
- Impact of Angiotensin Converting Enzyme Inhibitor versus Angiotensin Receptor Blocker on Incidence of New-Onset Diabetes Mellitus in Asians
-
Park JY, Rha SW, Choi BG, Choi SY, Choi JW, Ryu SK, Lee SJ, Kim S, Noh YK, Akkala RG, Li H, Ali J, Kim JB, Lee S, Na JO, Choi CU, Lim HE, Kim JW, Kim EJ, Park CG, Seo HS, Oh DJ
- KMID: 2466368
- Yonsei Med J.
- 2016 Jan;57(1):180-186.
- doi: 10.3349/ymj.2016.57.1.180
PURPOSE: Angiotensin converting enzyme inhibitor (ACEI) and angiotensin receptor blocker (ARB) are associated with a decreased incidence of new-onset diabetes mellitus (NODM). The aim of this study was to compare... -
- CITED
-
- Close
- SHARE
-
- Close
